Cargando…
MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt/β-cadherin pathway
BACKGROUND: Previous studies had shown that microRNA-638 (miR-638) exhibited different effects in malignant tumors. Moreover, the function of miR-638 has not been reported in breast cancer. Hence, we designed this research to explore the function of miR-638 in breast cancer. METHODS: Firstly, miR-63...
Autores principales: | Xu, Qian, Zhang, Qianqian, Dong, Mengli, Yu, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379838/ https://www.ncbi.nlm.nih.gov/pubmed/34416888 http://dx.doi.org/10.1186/s12957-021-02363-7 |
Ejemplares similares
-
MicroRNA-873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β-catenin pathway
por: Liu, Yilin, et al.
Publicado: (2022) -
miR-429 inhibits osteosarcoma progression by targeting HOXA9 through suppressing Wnt/β-catenin signaling pathway
por: Sun, Liangzhi, et al.
Publicado: (2020) -
MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9
por: Zhang, Zi-Feng, et al.
Publicado: (2017) -
Retraction: MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9
por: Zhang, Zi-Feng, et al.
Publicado: (2022) -
MicroRNA-638 inhibits cell growth and tubule formation by suppressing VEGFA expression in human Ewing sarcoma cells
por: Zhou, Xin, et al.
Publicado: (2018)